The biotech arena has been unusually active lately. One of the years’ biggest mergers occurred in biotech this week when we saw Actavis (ACT) acquire Allergan (AGN) for $66B (This was also one of the biggest #snubs when it rejected competitor Valeant’s (VRX) lesser $53B offer).
Additionally, Apple (APPL) launched its WatchKit developer program Wednesday, providing tools to build apps for the Apple Watch. Analysts anticipate that health-centric app offerings will grow exponentially over 2014.
On top of these happenings at the bigwigs, a slew of smaller companies and start-ups also received funding. Through Owler’s funding tracker we found that the biotech industry saw more funding events this week (20) than any other vertical, and an overall uptick in fundings from recent weeks. This increase comes as a number of new companies take on the challenge of improving access to healthcare data as well as at-home diagnosis tools. The graphic below shows some of the biggest events in the space this week. Discover the full breadth of these funding events on Owler. Check out the companies below to learn more about their funding events.